Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kylie Thaler, Divya V Chandiramani, Richard A Hansen & Gerald Gartlehner. (2009) Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project. Biologics: Targets and Therapy 3, pages 485-498.
Read now
Read now
. (2008) CD47-Fc fusion proteins as putative immunotherapeutic agents for the treatment of immunological and inflammatory diseases. Expert Opinion on Therapeutic Patents 18:5, pages 555-561.
Read now
Read now
Michael Campoli & Soldano Ferrone. (2008) Anti-inflammatory biologic therapies and immune surveillance of melanoma. Expert Review of Dermatology 3:2, pages 129-131.
Read now
Read now
Articles from other publishers (17)
Alan Kennedy, Maximillian A Robinson, Claudia Hinze, Erin Waters, Cayman Williams, Neil Halliday, Simon Dovedi & David M Sansom. (2023)
The
CTLA
‐4 immune checkpoint protein regulates
PD‐L1
:
PD
‐1 interaction via transendocytosis of its ligand
CD80
. The EMBO Journal 42:5.
Crossref
Crossref
Yulia Rodina, E. Deripapa, O. Shvets, A. Mukhina, A. Roppelt, D. Yuhacheva, A. Laberko, V. Burlakov, D. Abramov, G. Tereshchenko, G. Novichkova & Anna Shcherbina. (2021) Rituximab and Abatacept Are Effective in Differential Treatment of Interstitial Lymphocytic Lung Disease in Children With Primary Immunodeficiencies. Frontiers in Immunology 12.
Crossref
Crossref
Martina Doubková, Jana Špeldová & Zita Chovancová. (2019) Immunodeficiency in the differential diagnosis of interstitial lung diseases. Vnitřní lékařství 65:11, pages 685-693.
Crossref
Crossref
Amol Sagdeo, Ayman Askari, Josh Dixey, Hana Morrissey & Patrick A. Ball. (2019) Steroid-Sparing Agents in Giant Cell Arteritis. The Open Rheumatology Journal 13:1, pages 61-71.
Crossref
Crossref
S. A. Radygina, A. P. Vasilieva, S. N. Kozlovskaya, I. P. Shipitsyna, A. M. Livshits, E. I. Gutovskaya, L. N. Shelikhova & D. N. Balashov. (2019) Evaluation of abatacept for GVHD prophylaxis in patients with non-malignant diseases after hematopoietic stem cell transplantation. Pediatric Hematology/Oncology and Immunopathology 18:2, pages 22-29.
Crossref
Crossref
Benjamin K. Watkins, Victor Tkachev, Scott N. Furlan, Daniel J. Hunt, Kayla Betz, Alison Yu, Melanie Brown, Nicolas Poirier, Hengqi Betty Zheng, Agne Taraseviciute, Lucrezia Colonna, Caroline Mary, Gilles Blancho, Jean-Paul Soulillou, Angela Panoskaltsis-Mortari, Prachi Sharma, Anapatricia Garcia, Elizabeth Strobert, Kelly Hamby, Aneesah Garrett, Taylor Deane, Bruce R. Blazar, Bernard Vanhove & Leslie S. Kean. (2018) CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates. Journal of Clinical Investigation 128:9, pages 3991-4007.
Crossref
Crossref
Joseph R. Podojil, Iris Hecht, Ming-Yi Chiang, Ilan Vaknin, Inbal Barbiro, Amit Novik, Eyal Neria, Galit Rotman & Stephen D. Miller. (2018) ILDR2-Fc Is a Novel Regulator of Immune Homeostasis and Inducer of Antigen-Specific Immune Tolerance. The Journal of Immunology 200:6, pages 2013-2024.
Crossref
Crossref
Matthew J Koster, Eric L Matteson & Kenneth J Warrington. (2018) Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology 57:suppl_2, pages ii32-ii42.
Crossref
Crossref
N Verma, S O Burns, L S K Walker & D M Sansom. (2017) Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations. Clinical and Experimental Immunology 190:1, pages 1-7.
Crossref
Crossref
A. Guida, A. Tufano, P. Perna, P. Moscato, M. T. De Donato, R. Finelli, D. Caputo & M. N. D. Di Minno. (2014) The Thromboembolic Risk in Giant Cell Arteritis: A Critical Review of the Literature. International Journal of Rheumatology 2014, pages 1-7.
Crossref
Crossref
Divya T. Koura, John T. Horan, Amelia A. Langston, Muna Qayed, Aneesh Mehta, Hanna J. Khoury, R. Donald Harvey, Yvonne Suessmuth, Cynthia Couture, Jennifer Carr, Audrey Grizzle, Heather R. Johnson, Jennifer A. Cheeseman, Jason A. Conger, Jennifer Robertson, Linda Stempora, Brandi E. Johnson, Aneesah Garrett, Allan D. Kirk, Christian P. Larsen, Edmund K. Waller & Leslie S. Kean. (2013) In?Vivo T Cell Costimulation Blockade with Abatacept for?Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial. Biology of Blood and Marrow Transplantation 19:11, pages 1638-1649.
Crossref
Crossref
David M. Sansom & Lucy S. K. Walker. (2013)
CD
28 costimulation:
W
alking the immunological tightrope
. European Journal of Immunology 43:1, pages 42-45.
Crossref
Crossref
R. J. Moots & B. Naisbett-Groet. (2012) The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review. Rheumatology 51:12, pages 2252-2261.
Crossref
Crossref
Luciana Marti, Ricardo Golmia, Andrea Pimentel Fonseca Golmia, Ângela Tavares Paes, Daiane Donna Guilhen, Carlos Alberto Moreira-Filho & Morton Scheinberg. (2009) Alterations in Cytokine Profile and Dendritic Cells Subsets in Peripheral Blood of Rheumatoid Arthritis Patients before and after Biologic Therapy. Annals of the New York Academy of Sciences 1173:1, pages 334-342.
Crossref
Crossref
Giorgos Bamias, Spyros I. Siakavellas, Kimon S. Stamatelopoulos, Elda Chryssochoou, Christos Papamichael & Petros P. Sfikakis. (2008) Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis. Clinical Immunology 129:2, pages 249-255.
Crossref
Crossref
M. Pierer & C. Baerwald. (2008) Biologikatherapie bei rheumatologischen ErkrankungenBiological therapy for the treatment of rheumatic diseases. Der Internist 49:8, pages 938-946.
Crossref
Crossref
S.J. Enna, G.Z. Feuerstein, J. Piette & M. Williams. (2008) Fifty years of Biochemical Pharmacology: The discipline and the journal. Biochemical Pharmacology 76:1, pages 1-10.
Crossref
Crossref